NYSE: DBDDiebold Nixdorf Inc Stock
$0.95-1.35 (-58.7%)
Updated Mar 17, 2023
DBD Price
$0.95
Fair Value Price
N/A
Market Cap
$75.63M
52 Week Low
$0.86
52 Week High
$7.60
P/E
-0.13x
P/B
-0.05x
P/S
0.03x
PEG
N/A
Dividend Yield
N/A
Revenue
$3.46B
Earnings
-$581.40M
Gross Margin
21.9%
Operating Margin
-6.73%
Profit Margin
-16.8%
Debt to Equity
-3.21
Operating Cash Flow
-$388M
Beta
2.14
Next Earnings
May 8, 2023
Ex-Dividend
N/A
Next Dividend
N/A
DBD Overview
Diebold Nixdorf, Incorporated manufactures and services automated financial services prfoducts including automated teller machines (ATM), electronic and physical security equipment, and automated medication dispensing systems, among other products and services. Diebold Nixdorf was founded in 1859 and is headquartered in Hudson, OH.
Zen Score
–
Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how DBD scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
DBD is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
DBD is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
DBD's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 35 more DBD due diligence checks available for Premium users.
Be the first to know about important DBD news, forecast changes, insider trades & much more!
DBD News
Valuation
DBD price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.13x
Industry
145.47x
Market
21.81x
DBD price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-0.05x
Industry
5.03x
DBD's financial health
Profit margin
Revenue
$968.8M
Net Income
-$149.3M
Profit Margin
-15.4%
DBD's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
DBD's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$3.1B
Liabilities
$4.4B
Debt to equity
-3.21
DBD's short-term assets ($1.77B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
DBD's long-term liabilities ($2.83B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
DBD's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
DBD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$94.9M
Investing
-$23.0M
Financing
$116.3M
DBD's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
DBD vs App Stocks
Diebold Nixdorf Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.